• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vericel Corporation (NQ: VCEL )

    48.04 +3.29 (+7.35%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 806,127
    Open 47.35
    Bid (Size) 19.48 (1)
    Ask (Size) 52.00 (2)
    Prev. Close 44.75
    Today's Range 46.20 - 48.77
    52wk Range 32.28 - 54.10
    Shares Outstanding 46,631,158
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Earnings Preview For Vericel
    Via Benzinga
    Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024
    From Vericel Corporation
    Via GlobeNewswire

    Performance

    YTD
    +37.73%
    +37.73%
    1 Month
    +17.00%
    +17.00%
    3 Month
    +2.76%
    +2.76%
    6 Month
    -2.99%
    -2.99%
    1 Year
    +32.89%
    +32.89%

    More News

    Read More
    Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024
    From Vericel Corporation
    Via GlobeNewswire
    The Analyst Verdict: Vericel In The Eyes Of 7 Experts
    Via Benzinga
    Vericel Announces FDA Approval and Commercial Availability of MACI Arthro
    From Vericel Corporation
    Via GlobeNewswire
    Expert Ratings For Vericel
    Via Benzinga
    The Latest Analyst Ratings For Vericel
    Via Benzinga
    A Glimpse Into The Expert Outlook On Vericel Through 4 Analysts
    Via Benzinga
    Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
    From Vericel Corporation
    Via GlobeNewswire
    Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024
    From Vericel Corporation
    Via GlobeNewswire
    Apple To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Friday
    Via Benzinga
    Vericel Reports Second Quarter 2024 Financial Results
    From Vericel Corporation
    Via GlobeNewswire
    Critical Insights From Vericel Analyst Ratings: What You Need To Know
    Via Benzinga
    Analyst Scoreboard: 5 Ratings For Vericel
    Via Benzinga
    A Closer Look at 4 Analyst Recommendations For Vericel
    Via Benzinga
    Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
    From Vericel Corporation
    Via GlobeNewswire
    Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024
    From Vericel Corporation
    Via GlobeNewswire
    Trading SMID Biotech Stocks In A Volatile Market
    Via Talk Markets
    The 3 Highest-Rated Medical Stocks You Can Buy Today
    Via InvestorPlace
    Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024
    From Vericel Corporation
    Via GlobeNewswire
    Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024
    From Vericel Corporation
    Via GlobeNewswire
    VCEL Stock Earnings: Vericel Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance
    From Vericel Corporation
    Via GlobeNewswire
    Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
    From Vericel Corporation
    Via GlobeNewswire
    It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
    Via Talk Markets
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.